General MedicationsORALGeneric
THEOPHYLLINE
THEOPHYLLINE
Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview THEOPHYLLINE is listed in Drugs@FDA under application 089977 (ANDA).
Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 200MG Sponsor HOSPIRA Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview THEOPHYLLINE is listed in Drugs@FDA under application 089977 (ANDA). Marketing status: Discontinued Active ingredient THEOPHYLLINE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 200MG Sponsor HOSPIRA Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.